Master the female pelvis MRI protocol with a step-by-step framework covering high-resolution sagittal and oblique-axial T2, dual axial T1 with and without fat saturation, bladder-motion artifact control, and the scanning, interpretive, and clinical pitfalls that most often undermine accurate uterine and ovarian characterization.

Gynecologic MRI ✓ Medically Reviewed ⏱ 39 min read Day 16 of 30 — MRI Protocol Mastery Series

Female Pelvis MRI Protocol: The Complete Radiographer & Radiologist Guide

At a Glance

🧲 Sequences Used

High-resolution sagittal T2 (uterus/cervix long axis)
Oblique-axial T2 perpendicular to the endometrial canal/cervical canal
Axial T1 with and without fat saturation
Axial DWI (adnexal/endometrial lesion characterization)

💉 Contrast Protocol

10–15 mL (0.1 mmol/kg) gadolinium-based agent at 2.0 mL/s, followed by a 100 mL saline chaser at 2.0 mL/s, when dynamic post-contrast assessment of an adnexal or endometrial lesion is clinically indicated.

🎯 Artifact Reduction

Primary artifact: bladder motion/pulsation. Remedy: instruct partial bladder filling before scanning and apply anterior abdominal wall saturation bands to suppress ghosting propagating across the pelvis.

⚠️ Key Pitfalls

Radiographers: scanning with an overdistended or empty bladder
Radiologists: bladder pulsation ghost mistaken for an adnexal lesion
Referrers: acting on ultrasound and MRI reports as directly interchangeable

Table of Contents

Introduction
Female Pelvic Anatomy Essentials
MR Tissue Relaxation Values
Scanning Technique — 10 Steps
Contrast Media Protocol
Specific Absorption Rate & Dose Reduction
Top 10 Pathologies
Pitfalls — Radiographers
Pitfalls — Radiologists
Pitfalls — Non-Radiology Physicians
Pitfall Comparison Summary
AI & Automation in Female Pelvis MRI
Further Reading
Reducing Artefacts with Patients and Parameters
Parallel Imaging Protocols and Parameters
Conclusion
References

Introduction

A well-executed female pelvis MRI protocol is the reference-standard problem-solving tool for uterine and ovarian pathology that ultrasound leaves equivocal, and the definitive local staging modality for endometrial and cervical carcinoma. Because pelvic organ position, orientation, and even zonal anatomy shift meaningfully with bladder volume and bowel peristalsis, this protocol is unusually dependent on deliberate patient preparation — a detail that separates a diagnostic study from one degraded by exactly the motion artifact this guide is built around.

Unlike many oncologic MRI protocols where contrast is mandatory, female pelvis MRI is frequently performed non-contrast for benign indications such as fibroid mapping or Müllerian anomaly characterization, with dynamic post-contrast imaging reserved for endometrial/cervical cancer staging and indeterminate adnexal mass characterization. Knowing which clinical question is being asked therefore directly shapes whether contrast is needed at all — a protocol decision this guide addresses explicitly in the contrast section below.

Clinical Context MRI’s ability to distinguish the uterine zonal anatomy — endometrium, junctional zone, and myometrium — on T2-weighted imaging is what makes it uniquely suited to differentiate adenomyosis from leiomyoma, stage endometrial cancer myometrial invasion depth, and assess cervical stromal ring integrity in cervical cancer. None of this zonal detail is reliably reproducible without genuinely orthogonal sagittal and oblique-axial planning relative to the individual patient’s uterine axis, which is why generic axial-only protocols systematically underperform a properly planned female pelvis study.

This guide walks through the complete female pelvis MRI workflow: the uterine and ovarian anatomy that dictates sequence planning, relevant relaxation values, a ten-step scanning technique, the contrast protocol and when it is and is not required, SAR-conscious parameter selection, the top ten pathologies the protocol is built to detect, and the distinct pitfalls that affect radiographers at the console, radiologists at the workstation, and referring gynecologists acting on the report.

🩺

Reliable Contrast Delivery with SATline

Consistent, kink-resistant tubing supports reproducible dynamic timing when adnexal or endometrial contrast assessment is indicated.

Explore SATline →

Female Pelvic Anatomy Essentials

The uterus, cervix, and ovaries occupy the true pelvis between the bladder anteriorly and the rectosigmoid colon posteriorly — a sandwich relationship that makes bladder and bowel preparation genuinely inseparable from image quality, not merely a courtesy to patient comfort.

Uterine zonal anatomy

On T2-weighted imaging, the normal uterine corpus displays three distinct signal layers. The endometrium is markedly T2 hyperintense, varying in thickness with menstrual cycle phase. The junctional zone — the innermost myometrial layer — is a thin, well-defined band of relatively low T2 signal, and its thickness is the central discriminator in adenomyosis diagnosis (a junctional zone ≥12 mm is considered abnormal). The outer myometrium is intermediate T2 signal, relatively homogeneous in the normal uterus, and the layer against which leiomyoma and myometrial tumor invasion are assessed.

Cervix

The cervix shows a comparable, though distinct, zonal pattern: a central T2-hyperintense mucosal/endocervical canal signal, surrounded by a low-signal-intensity fibrous cervical stroma — the cervical stromal ring — whose integrity is the key determinant of parametrial invasion in cervical cancer staging.

Ovaries and adnexa

The ovaries are variably positioned but most commonly located in the ovarian fossa lateral to the uterus, and their MRI appearance varies substantially with menstrual cycle phase due to follicular development and corpus luteum formation. The adnexa — ovaries, fallopian tubes, and surrounding broad ligament tissue — is the site of origin of the mass lesions this protocol is frequently obtained to characterize, and normal fallopian tubes are not typically visualized unless distended by fluid, blood, or pus.

Clinical Anatomy Pearl Uterine position — anteverted, retroverted, or axial — and cervical angulation vary substantially between patients and even between scans in the same patient depending on bladder and rectal filling. This is precisely why oblique-axial and oblique-coronal planes must be individually prescribed relative to the endometrial canal on the sagittal localizer for each patient, rather than applied as a fixed generic angle.

MR Tissue Relaxation Values

Understanding baseline T1 and T2 relaxation times of normal uterine and ovarian tissue underpins correct recognition of the zonal and adnexal signal abnormalities this protocol is designed to detect.

Structure	T1 (ms) @ 1.5T	T1 (ms) @ 3T	T2 (ms) @ 1.5T	T2 (ms) @ 3T
Endometrium (secretory phase)	~1300–1500	~1600–1850	~110–140	~95–120
Junctional zone	~900–1000	~1150–1300	~35–50	~30–42
Outer myometrium	~1150–1250	~1450–1550	~70–90	~60–78
Cervical stroma	~950–1050	~1200–1350	~40–55	~35–48
Ovarian follicular fluid	~2200–2800	~2700–3200	>150	>150
Skeletal muscle (reference)	~870	~1420	~47	~32

This relaxation profile explains the fundamental “black stripe” appearance of the junctional zone relative to the brighter outer myometrium and endometrium, and why loss or thickening of this low-signal band — rather than myometrial signal change alone — is the primary MRI signature of adenomyosis. It also explains why simple ovarian follicular cysts appear uniformly hyperintense on T2, similar to simple cysts elsewhere in the body, while a hemorrhagic cyst or endometrioma shows the markedly different T1-hyperintense, T2 “shading” pattern discussed in the pathology section below.

Scanning Technique — 10 Steps

Patient preparation and bladder instruction. Instruct the patient to partially empty the bladder 1–2 hours before scanning, aiming for a moderately, not maximally, distended bladder — sufficient to displace bowel loops without inducing motion-provoking discomfort or urgency.
Antispasmodic/bowel prep consideration. Consider an antispasmodic agent to reduce bowel peristalsis in patients with a history of motion-degraded prior studies, per departmental protocol.
Coil selection and positioning. Use a torso/pelvic phased-array coil positioned to cover the uterine fundus superiorly and the full cervix and upper vagina inferiorly.
Sagittal T2 localizer. Acquire a high-resolution sagittal T2 sequence first — this defines the uterine and cervical long axis used to prescribe every subsequent oblique plane.
Oblique-axial T2 (short axis of the uterine corpus). Prescribe perpendicular to the endometrial canal as visualized on the sagittal localizer, essential for accurate junctional zone and myometrial invasion assessment.
Oblique-axial T2 (short axis of the cervix), when relevant. Prescribe perpendicular to the cervical canal for cervical stromal ring assessment in suspected or known cervical pathology.
Axial T1 without fat saturation. Acquire a standard axial T1 sequence across the full pelvis to identify T1-hyperintense lesions such as hemorrhagic cysts, endometriomas, or dermoid cysts.
Axial T1 with fat saturation. Acquire the paired fat-saturated sequence to confirm macroscopic fat (dermoid) versus blood products (endometrioma/hemorrhagic cyst) — fat suppresses, blood does not.
Axial DWI. Acquire diffusion-weighted imaging with ADC map generation to support adnexal and endometrial lesion characterization, particularly for suspected malignancy.
Dynamic post-contrast 3D T1 fat-saturated (when indicated). For endometrial/cervical cancer staging or indeterminate adnexal masses, administer the gadolinium bolus and acquire a dynamic series to assess myometrial invasion depth, parametrial invasion, or adnexal lesion enhancement pattern.

Scanner comparison table (1.5T vs. 3.0T)

Parameter	1.5T	3.0T
Junctional zone conspicuity	Good, standard resolution	Improved, supports finer zonal-thickness measurement
SNR	Baseline	~1.7–2× higher, supporting higher in-plane resolution T2
Fat suppression uniformity across the pelvis	Generally more homogeneous	More prone to peripheral fat-sat failure at the pelvic sidewalls — Dixon-based methods often preferred
SAR headroom for the multi-plane T2 + T1 ± FS block	Greater	More restrictive; turbo factor and flip angle moderation typically required
Bladder pulsation ghosting severity	Less pronounced	Can be more conspicuous — saturation band strength and placement become more critical

💉

Precision-Filled Syringes with SATSyringe

Accurately dosed, air-bubble-minimized syringes support reliable dynamic post-contrast timing for endometrial and cervical cancer staging.

Explore SATSyringe →

Contrast Media Protocol

Unlike several other protocols in this series, contrast is not universally required for female pelvis MRI — its use is indication-specific, and recognizing when it adds genuine diagnostic value versus when it is unnecessary is itself a protocol decision.

Injection Protocol (When Indicated)

Volume: 10–15 mL (0.1 mmol/kg) gadolinium-based contrast agent
Flow rate: 2.0 mL/s
Chaser: 100 mL saline at 2.0 mL/s
Acquisition: Dynamic 3D T1 fat-saturated series, timed to the specific clinical question (early dynamic phases for myometrial invasion assessment; delayed phases for cervical stromal invasion)

Contrast is most clearly indicated for endometrial cancer myometrial invasion staging (where the enhancing myometrium contrasts against a relatively less-enhancing tumor), cervical cancer parametrial assessment, and characterization of a solid or complex adnexal mass where enhancement pattern helps distinguish benign from malignant features. It is frequently omitted for straightforward fibroid mapping, simple cyst characterization, or Müllerian duct anomaly assessment, where T2 morphology alone is sufficient.

Safety Check Confirm eGFR before gadolinium administration per standard institutional and ACR Manual on Contrast Media guidance, and confirm pregnancy status is excluded or the risk-benefit discussion has been documented, since gadolinium crosses the placenta and is generally avoided in pregnancy unless the diagnostic benefit clearly outweighs the theoretical risk.

Specific Absorption Rate & Dose Reduction

The combination of multiple high-resolution T2 sequences in different obliquities, paired T1 with and without fat saturation, and — when indicated — dynamic post-contrast imaging makes this a moderately RF-intensive protocol, particularly at 3T.

Regulatory Body	Whole-body SAR limit (normal mode)	Relevance to female pelvis protocol
ICRP	Guidance framework for RF exposure, not device-specific limits	Underpins the general ALARA principle applied to RF exposure across this multi-plane protocol
IEC 60601-2-33 / adopted by EC RP 185	2 W/kg whole-body (normal operating mode)	Governs the cumulative RF load of multiple oblique T2, paired T1 ± FS, and dynamic sequences performed in one sitting
AAPM	Practice guidance aligned with IEC limits; emphasizes local monitoring	Recommends departmental SAR auditing for multi-sequence pelvic protocols, particularly at 3T

Five dose reduction strategies

Limit oblique T2 acquisitions to those genuinely required by the clinical question rather than acquiring every possible obliquity by default.
Employ parallel imaging on T2 and dynamic T1 sequences to reduce total RF pulses per acquisition.
Use Dixon-based fat suppression rather than stacked spectral presaturation pulses, particularly at 3T where fat-sat uniformity is more challenging across the pelvis.
Reserve dynamic post-contrast imaging for indications where it changes management, rather than acquiring it routinely for every study.
Moderate turbo factor on T2 sequences to balance spatial resolution — essential for junctional zone measurement — against RF duty cycle.

🧪

Consistent Bolus Geometry with SATMix

Standardized contrast-to-saline mixing supports reliable enhancement assessment when myometrial or adnexal contrast characterization is required.

Explore SATMix →

Top 10 Pathologies

Uterine leiomyoma (fibroid)

T1: iso-to-hypointense · T2: well-circumscribed, markedly hypointense to myometrium

The most common uterine pathology; degeneration subtypes alter signal and are relevant to pre-treatment mapping.

Adenomyosis

T1: unremarkable · T2: thickened junctional zone (≥12 mm), ill-defined margins

Distinguished from leiomyoma by ill-defined borders and junctional zone thickening rather than a discrete mass.

Endometrial carcinoma

T1: iso-to-hypointense · T2: intermediate signal mass disrupting the junctional zone

Dynamic contrast is central to myometrial invasion depth staging (<50% vs. ≥50%).

Cervical carcinoma

T1: unremarkable · T2: intermediate-signal mass disrupting the low-signal cervical stromal ring

Stromal ring integrity is the key determinant of parametrial invasion and FIGO stage.

Endometrioma

T1: hyperintense (does not suppress on FS) · T2: “shading” — hypointense relative to simple cysts

The T2 shading sign reflects repeated cyclical hemorrhage and is a key diagnostic discriminator.

Mature cystic teratoma (dermoid)

T1: hyperintense (suppresses on FS, unlike endometrioma) · T2: heterogeneous, may show a fat-fluid level

Macroscopic fat suppression on FS T1 is the key discriminator from endometrioma.

Serous/mucinous cystadenoma

T1: hypointense · T2: hyperintense, thin-walled, uni- or multilocular

Thin, smooth walls without solid enhancing components favor benignity.

Tubo-ovarian abscess

T1: hypointense center, hyperintense rim · T2: markedly hyperintense, thick irregular wall

Restricted diffusion and adjacent inflammatory stranding support the diagnosis in the correct clinical context.

Ovarian torsion

T1: variable, hemorrhagic changes if infarcted · T2: enlarged, edematous ovary

An enlarged, edematous ovary with peripherally displaced follicles is a key supporting sign; time-sensitive diagnosis.

Müllerian duct anomaly (e.g., bicornuate/septate uterus)

T1: unremarkable · T2: abnormal fundal contour and/or duplicated endometrial cavities

External fundal contour on coronal T2 is the key discriminator between septate (normal/minimally indented) and bicornuate (deeply indented) uterus.

🔬

Confident Lesion Characterization Starts with SATline

Reliable, consistent contrast delivery lines support the enhancement assessment adnexal and endometrial characterization depends on.

Explore SATline →

Pitfalls — Radiographers

Primary scanning pitfall (from protocol data): Bladder motion/pulsation artifact, arising from scanning with an inappropriately filled (either overdistended or empty) bladder and inadequate saturation band placement.

Category	Description	Mitigation
Overdistended or empty bladder	A maximally full bladder increases pulsatile motion and patient discomfort-related bulk motion; an empty bladder allows bowel loops to prolapse into the pelvis, obscuring the adnexa and uterus.	Instruct partial bladder filling (moderate, comfortable distention) 1–2 hours before scanning rather than either extreme.
Missing or under-strength anterior saturation band	Omitting the anterior abdominal wall saturation band, or applying it with inadequate strength/coverage, allows bladder pulsation ghosting to propagate across the phase-encoding direction directly over the uterus and adnexa.	Apply a dedicated anterior abdominal wall saturation band by protocol default, positioned to cover the full bladder dome.
Non-orthogonal oblique planning	Prescribing the oblique-axial T2 sequence from a generic angle rather than truly perpendicular to the individual patient’s endometrial or cervical canal.	Always re-plan the oblique-axial sequence directly from that patient’s sagittal localizer, never from a saved generic angle.
Phase-encoding direction not optimized	Leaving phase-encoding direction in a default orientation that places bladder and bowel motion artifact directly across the uterus/adnexa.	Set phase-encoding direction to project motion artifact away from the pelvic organs of interest, consistent with standard artifact-management principles.
Incomplete fat-sat pairing on T1	Acquiring only non-fat-saturated or only fat-saturated axial T1, rather than the required pair, loses the ability to distinguish fat-containing from hemorrhagic lesions.	Confirm both T1 sequences are acquired as a pair by protocol default whenever an adnexal lesion is identified or suspected.

Pitfalls — Radiologists

Primary interpretation pitfall (from protocol data): Bladder pulsation ghost artifact projecting over the adnexa mistaken for a true adnexal lesion, or conversely obscuring a genuine small lesion beneath overlying ghosting.

Pitfall	Mechanism	Consequence	Mitigation
Pulsation ghost misread as adnexal lesion	Periodic bladder motion propagates discrete ghost signal along the phase-encoding direction, which can superimpose over the adnexa and mimic a solid or cystic mass on a single sequence.	False-positive adnexal finding, unnecessary follow-up imaging or referral.	Confirm any suspected adnexal finding is present in the same location across multiple sequences and planes before reporting it as a true lesion; ghosting typically does not persist consistently across independently acquired sequences.
Junctional zone thickness measured on a non-true short-axis plane	Measuring junctional zone thickness on an obliquely angled, non-perpendicular axial sequence overestimates or underestimates true thickness.	False-positive or false-negative adenomyosis diagnosis.	Confirm the oblique-axial sequence is genuinely perpendicular to the endometrial canal before using it for junctional zone measurement; remeasure on sagittal imaging if oblique planning is suboptimal.
Endometrioma and dermoid cyst confused	Both are T1-hyperintense adnexal lesions; failing to review the fat-saturated T1 sequence specifically to confirm fat suppression (dermoid) versus persistence (endometrioma) risks conflating the two.	Incorrect pre-surgical counseling and lesion characterization.	Always confirm T1 fat-saturated signal behavior explicitly before finalizing the distinction between these two common T1-hyperintense adnexal lesions.
Myometrial invasion depth misjudged from a mistimed dynamic phase	Assessing invasion depth on a dynamic phase acquired too early or too late relative to peak myometrial-to-tumor contrast.	Inaccurate FIGO stage assignment, affecting surgical planning.	Review the full dynamic series rather than a single phase, identifying the phase of maximal myometrial-tumor contrast difference for invasion depth assessment.

Pitfalls — Non-Radiology Physicians

Pitfall	What they see	What it actually is	Clinical danger	What to do
Treating ultrasound and MRI findings as directly interchangeable	A prior ultrasound-based adnexal mass description compared directly to a new MRI report	MRI’s superior soft-tissue contrast frequently characterizes lesions ultrasound left indeterminate, or applies different descriptive terminology for the same finding	Confusing modality-driven differences in description for true interval change	Request the MRI report’s own characterization rather than reconciling it against the ultrasound description independently; ask radiology to clarify any apparent discrepancy
Ordering contrast-enhanced MRI without confirming pregnancy status	A standing order for “pelvis MRI with contrast” in a reproductive-age patient	A patient whose pregnancy status has not been confirmed, creating a gadolinium risk-benefit question that should be resolved before, not during, the scan	Avoidable exposure or last-minute protocol change	Confirm pregnancy status (or exclude it via urine/serum testing per institutional policy) before ordering contrast-enhanced pelvic MRI in reproductive-age patients
Assuming “no bladder distention noted” limits diagnostic reliability	A technical note about bladder filling in the report body	A comment on bowel-displacement adequacy, not necessarily a limiting factor for uterine/adnexal assessment specifically	Unwarranted request for a repeat scan when the actual study was diagnostic for the clinical question asked	Ask radiology directly whether the technical note materially affects confidence in the specific finding of clinical concern, rather than assuming any noted limitation invalidates the study
Managing adnexal masses on MRI descriptor alone without risk stratification	A morphologic description (e.g., “complex cystic adnexal lesion”) without an integrated risk assessment	A finding requiring integration with a structured risk-stratification framework and clinical context (menopausal status, tumor markers) before management decisions	Over- or under-treatment based on descriptive language alone	Discuss findings with radiology/gynecologic oncology using a structured risk framework rather than acting on morphologic description in isolation

📋

Reduce Repeat Scans with SATSyringe

Consistent, accurately dosed contrast delivery reduces mistimed dynamic phases that lead to equivocal staging reports.

Explore SATSyringe →

Pitfall Comparison Summary

🟡 Scanning (Radiographers)

Overdistended or empty bladder
Missing/weak anterior saturation band
Non-orthogonal oblique planning
Phase-encoding direction not optimized
Incomplete T1 ± FS pairing

🔴 Interpretation (Radiologists)

Pulsation ghost misread as adnexal lesion
Junctional zone mismeasured off-axis
Endometrioma/dermoid confusion
Myometrial invasion misjudged from wrong phase

🟣 Clinical (Physicians)

Treating US and MRI as interchangeable
Ordering contrast without pregnancy check
Misreading technical limitation notes
Managing masses on descriptor alone

AI & Automation in Female Pelvis MRI

Automated uterine and adnexal segmentation tools, junctional zone thickness quantification, and structured risk-stratification-assistive scoring for adnexal masses are increasingly available as CE-marked adjuncts to female pelvis MRI reporting. These tools help standardize measurements that are otherwise dependent on precise oblique-plane execution — directly addressing the off-axis junctional zone measurement pitfall discussed above — and support more consistent adnexal mass risk communication across a department’s reporting workload.

As with other structured frameworks in this series, these tools function as a consistency aid rather than a replacement for radiologist judgment, particularly for the genuinely difficult task of distinguishing benign from borderline or malignant adnexal morphology.

🧪

Consistent Inputs Make Better Outputs — SATMix

Whatever quantification or scoring software your department uses, standardized contrast mixing keeps the enhancement data feeding it reliable.

Explore SATMix →

Reducing Artefacts with Patients and Parameters

The most critical scanning parameters that impact image quality include:

1. Spatial Resolution

Spatial resolution defines the ability to distinguish small details in an image. Matrix Size: Increasing the matrix size (frequency × phase) increases spatial resolution, but decreases SNR because the voxel (3D pixel) size becomes smaller. Field of View (FOV): Reducing the FOV increases spatial resolution. However, smaller FOV results in smaller voxels and reduces SNR. Slice Thickness: Thinner slices provide higher spatial resolution and reduce partial volume averaging, but significantly decrease SNR.

2. Signal-to-Noise Ratio (SNR)

SNR represents the strength of the diagnostic signal relative to inherent background noise. A high SNR produces crisp, clear images, whereas a low SNR looks grainy. Number of Averages (NEX/NSA): Increasing averages acquires data multiple times, which improves SNR. However, doubling the averages roughly doubles the scan time. Receiver Bandwidth: Decreasing the bandwidth limits the amount of noise recorded, boosting SNR. However, a lower bandwidth increases scan times and chemical shift artifacts. Coil Selection: Using dedicated, localized surface coils rather than whole-body coils captures much stronger signals and heavily improves SNR.

3. Image Contrast

Contrast determines how different tissues are distinguished from one another (e.g., highlighting bone vs. fluid vs. muscle). Repetition Time (TR): TR is the time between consecutive RF pulses. A short TR maximizes T1 tissue contrast, while a long TR minimizes it. Echo Time (TE): TE is the time between the RF pulse and the peak of the echo signal. A short TE minimizes T2 effects, and a long TE maximizes T2 weighting, making fluid-filled areas appear very bright. Flip Angle: Controls the excitation of protons. Adjusting the flip angle changes tissue contrast and is especially critical in gradient echo sequences.

4. Artifact Control

Artifacts are visual distortions or ghosting that degrade image quality. Phase Encoding Direction: Swapping the phase and frequency axes can shift motion-induced artifacts (like breathing or blood flow) away from the primary region of interest. Flow Compensation / Gating: Utilizes physiological triggers (e.g., electrocardiogram) to minimize blurring and ghosting caused by pulsatile motion. Parallel Imaging: Utilizes multiple coil elements simultaneously to reduce phase encoding steps, significantly cutting down scan time and reducing motion artifacts.

Parallel Imaging Protocols and Parameters

Parallel imaging acceleration helps balance the high spatial resolution required for junctional zone and cervical stromal ring assessment against total exam time in a protocol that already requires multiple obliquities.

Sequence	Parameter	1.5T typical setting	3.0T typical setting	Adjustment for optimal quality
Sagittal/oblique-axial T2	Turbo factor (echo train length)	16–24	16–24	Keep turbo factor moderate to preserve the fine zonal detail junctional zone and cervical stromal ring assessment depend on
Axial T1 (± FS)	Parallel imaging factor	2×	2–3×	Higher factor at 3T shortens acquisition, reducing cumulative exam time and bladder-filling drift between sequences
DWI (EPI)	Parallel imaging factor	2×	2–3×	Higher factor at 3T reduces geometric distortion from susceptibility effects near bowel gas
Dynamic 3D T1 FS	Acceleration (SENSE/GRAPPA) factor	2×	2–3× (SAR headroom permitting)	Increase acceleration at 3T primarily to shorten dynamic phase duration when myometrial or cervical invasion timing is time-critical

As a general principle: increasing turbo/acceleration factor shortens acquisition — reducing the cumulative time over which bladder filling can drift and introduce inter-sequence inconsistency — but can blur fine zonal detail relevant to junctional zone and stromal ring assessment. The optimal balance favors moderate turbo factors on the diagnostic T2 sequences, with higher acceleration reserved for T1 and dynamic sequences where fine zonal detail is less critical than overall exam efficiency.

Conclusion

A technically sound female pelvis MRI protocol rests on four pillars: deliberate bladder-filling instruction and saturation band technique to manage the pulsation artifact that most directly threatens diagnostic confidence in the adnexa; individually planned sagittal and oblique-axial T2 sequences genuinely orthogonal to each patient’s uterine and cervical anatomy; a clear, indication-specific approach to contrast use rather than a one-size-fits-all injection; and disciplined awareness of the distinct pitfall patterns that affect radiographers at acquisition, radiologists at interpretation, and referring gynecologists acting on the final report.

From uterine leiomyoma and adenomyosis through endometrial and cervical carcinoma staging and the genuinely challenging benign-versus-malignant adnexal mass distinction, the protocol’s diagnostic power depends on treating bladder preparation, precise oblique planning, and structured reporting as inseparable parts of a single pathway. Departments that standardize bladder-filling instructions, saturation band placement, and oblique-plane execution consistently produce more diagnostic, less ambiguous female pelvis MRI reports.

References

American College of Radiology. (2023). ACR manual on contrast media (Version 2023). American College of Radiology. acr.org/Clinical-Resources/Contrast-Manual
Sala, E., Rockall, A. G., Freeman, S. J., Mitchell, D. G., & Reinhold, C. (2013). The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: What the radiologist needs to know. Radiology, 266(3), 717–740. https://doi.org/10.1148/radiol.12120315
Bharwani, N., Reznek, R. H., & Rockall, A. G. (2011). Endometrial and cervical cancer: MR imaging-based staging. Magnetic Resonance Imaging Clinics of North America, 19(3), 599–621. https://doi.org/10.1016/j.mric.2011.05.008
Woodward, P. J., Sohaey, R., & Mezzetti, T. P. (2001). Endometriosis: Radiologic-pathologic correlation. RadioGraphics, 21(1), 193–216. https://doi.org/10.1148/radiographics.21.1.g01ja14193
Bazot, M., & Darai, E. (2017). Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis. Fertility and Sterility, 108(6), 886–894. https://doi.org/10.1016/j.fertnstert.2017.10.026
Thomassin-Naggara, I., Aubert, E., Rockall, A., Jalaguier-Coudray, A., Rouzier, R., Daraï, E., & Bazot, M. (2013). Adnexal masses: Development and preliminary validation of an MR imaging scoring system. Radiology, 267(2), 432–443. https://doi.org/10.1148/radiol.13121161
Thomassin-Naggara, I., Poncelet, E., Jalaguier-Coudray, A., Guerra, A., Fournier, L. S., Stojanovic, S., Millet, I., Bharwani, N., Juhan, V., Cunha, T. M., Masselli, G., Argay, A. G., Balleyguier, C., Malhaire, C., Perrot, N., Camaioni, C., Sadowski, E., Reinhold, C., & Rockall, A. (2020). Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) score for risk stratification of sonographically indeterminate adnexal masses. JAMA Network Open, 3(1), e1919896. https://doi.org/10.1001/jamanetworkopen.2019.19896
Forstner, R., Sala, E., Kinkel, K., Spencer, J. A., & European Society of Urogenital Radiology. (2010). ESUR guidelines: Ovarian cancer staging and follow-up. European Radiology, 20(12), 2773–2780. https://doi.org/10.1007/s00330-010-1886-2
Kido, A., Ascher, S. M., Hahn, W., Kishimoto, K., Kashitani, N., Jha, R. C., Togashi, K., & Hussain, S. M. (2016). Comparison of MRI diagnostic performance for adenomyosis using the presence and severity of disease as reference standard. American Journal of Roentgenology, 207(1), 121–129. https://doi.org/10.2214/AJR.15.15665
Behr, S. C., Courtier, J. L., & Qayyum, A. (2012). Imaging of Müllerian duct anomalies. RadioGraphics, 32(6), E233–E250. https://doi.org/10.1148/rg.326125515
Robbins, J. B., Broadwell, C., Chow, L. C., Parry, J. P., & Sadowski, E. A. (2015). Müllerian duct anomalies: Embryological development, classification, and MRI assessment. Journal of Magnetic Resonance Imaging, 41(1), 1–12. https://doi.org/10.1002/jmri.24771
Duigenan, S., Oliva, E., & Lee, S. I. (2012). Ovarian torsion: Diagnostic features on CT and MRI with pathologic correlation. American Journal of Roentgenology, 198(2), W122–W131. https://doi.org/10.2214/AJR.10.7293
Rha, S. E., Byun, J. Y., Jung, S. E., Jung, J. I., Choi, B. G., Kim, B. S., Kim, H., & Lee, J. M. (2002). CT and MR imaging features of adnexal torsion. RadioGraphics, 22(2), 283–294. https://doi.org/10.1148/radiographics.22.2.g02mr02283
Nougaret, S., Tirumani, S. H., Addley, H., Pandey, H., Sala, E., & Reinhold, C. (2013). Pearls and pitfalls in MRI of gynecologic malignancy with diffusion-weighted technique. American Journal of Roentgenology, 200(2), 261–276. https://doi.org/10.2214/AJR.12.9713
Levin, A., & Stevens, P. E. (2024). Executive summary of the KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International, 105(4), 684–701. https://doi.org/10.1016/j.kint.2023.10.016
European Society of Urogenital Radiology. (2018). ESUR guidelines on contrast agents (Version 10.0). ESUR. esur.org/esur-guidelines-on-contrast-agents
Manganaro, L., Lakhman, Y., Bharwani, N., Gui, B., Gigli, S., Vinci, V., Rizzo, S., Kido, A., Cunha, T. M., Sala, E., Forstner, R., & Nougaret, S. (2021). Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018. European Radiology, 31(101), 7802–7816. https://doi.org/10.1007/s00330-020-07632-9
Nougaret, S., Horta, M., Sala, E., Lakhman, Y., Thomassin-Naggara, I., Kido, A., Masselli, G., Bharwani, N., Sadowski, E., Ertmer, A., Otero-Garcia, M., Peungjesada, S., Fujii, S., Zaspel, U., Rockall, A., Forstner, R., & Reinhold, C. (2019). Endometrial cancer MRI staging: Updated guidelines of the European Society of Urogenital Radiology. European Radiology, 29(2), 792–805. https://doi.org/10.1007/s00330-018-5515-y
Spencer, J. A., Ghattamaneni, S. (2010). MR imaging of the sonographically indeterminate adnexal mass. Radiology, 256(3), 677–694. https://doi.org/10.1148/radiol.10090397
Bharwani, N., Nougaret, S., & Sadowski, E. (2020). Comparing 2018 International Federation of Gynecology and Obstetrics (FIGO) staging of cervical cancer with MRI. British Journal of Radiology, 93(1113), 20200226. https://doi.org/10.1259/bjr.20200226
International Commission on Radiological Protection. (2020). ICRP publication 147: Use of dosimetric quantities for regulatory purposes. ICRP. icrp.org/publication.asp?id=ICRP Publication 147
SATMED Health. (2026, May 31). 7 proven strategies for optimizing MRI sequences in 2026. https://www.satmed-health.com/optimizing-mri-sequences/
SATMED Health. (2026, March 1). 2026 contrast media guidelines: eGFR thresholds & safe administration protocol. https://www.satmed-health.com/2026-worldwide-guidelines…
Kubik-Huch, R. A., Weston, M., Nougaret, S., Leonhardt, H., Thomassin-Naggara, I., Horta, M., Cunha, T. M., Maunoury, V., Rockall, A., Bhosale, P., Forstner, R., & Sala, E. (2018). European Society of Urogenital Radiology (ESUR) guidelines: MR imaging of leiomyomas. European Radiology, 28(8), 3125–3137. https://doi.org/10.1007/s00330-017-5157-5
Deshmukh, S. P., Gonsalves, C. F., Guglielmo, F. F., & Mitchell, D. G. (2012). Role of MR imaging of uterine leiomyomas before and after embolization. RadioGraphics, 32(6), E251–E281. https://doi.org/10.1148/rg.326125517
Foti, P. V., Farina, R., Palmucci, S., Vizzini, I. A. A., Libertini, N., Coronella, M., Spadola, S., Caltabiano, R., Iemmolo, R. M., Milone, P., Cianci, A., & Ettorre, G. C. (2018). Endometriosis: Clinical features, MR imaging findings and pathologic correlation. Insights into Imaging, 9(2), 149–172. https://doi.org/10.1007/s13244-017-0591-0
Outwater, E. K., Siegelman, E. S., & Hunt, J. L. (2001). Ovarian teratomas: Tumor types and imaging characteristics. RadioGraphics, 21(2), 475–490. https://doi.org/10.1148/radiographics.21.2.g01mr09475
Kim, S. H., Kim, S. H., Yang, D. M., & Kim, K. A. (2004). Unusual causes of tubo-ovarian abscess: CT and MR imaging findings. RadioGraphics, 24(6), 1575–1589. https://doi.org/10.1148/rg.246045016
American College of Radiology. (2022). ACR–ACOG–AIUM–SRU practice parameter for the performance of magnetic resonance imaging (MRI) of the female pelvis. American College of Radiology. acr.org practice parameter — MRI of the female pelvis
Expert Panel on GYN and OB Imaging, Kang, S. K., Lockhart, M. E., Andreotti, R. F., Angel, K. M., Fulcher, A. S., Harringa, J. B., Jones, M. A., Nougaret, S., Pandharipande, P. V., Suarez, J. A., Uyeda, J. W., Wall, D. J., Whitcomb, B. P., Zelop, C. M., & Glanc, P. (2018). ACR Appropriateness Criteria: Clinically suspected adnexal mass. Journal of the American College of Radiology, 15(5), S198–S207. https://doi.org/10.1016/j.jacr.2018.03.014

Medically Reviewed by Prof. Dr. Damien O’Neil, MD, PhD

Last updated: July 8, 2026 | Reviewed for clinical accuracy and adherence to the latest guidelines of the European Society of Urogenital Radiology (ESUR), American College of Radiology (ACR), Radiological Society of North America (RSNA), the International Federation of Gynecology and Obstetrics (FIGO), and the International Commission on Radiological Protection (ICRP).

(Organisations adjusted to those relevant to gynecologic/pelvic protocols.)

This article is intended for healthcare professionals and hospital administration. It does not constitute individual clinical advice. Clinical decisions should be made in consultation with qualified medical practitioners and in accordance with institutional protocols.

Female Pelvis MRI Protocol: 10 Steps to Master Scans